Document Detail


Prevalence and lifetime healthcare cost of cerebral palsy in South Korea.
MedLine Citation:
PMID:  20952086     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
OBJECTIVES: This study examined the prevalence of cerebral palsy (CP) in South Korea, and the attributable lifetime medical cost according to physiological types and extent of involvement.
METHODS: The number of medical service use and medical cost of CP were obtained from the national health insurance review and assessment (HIRA) service. The prevalence was calculated from the number of five-year-old patients who used medical services between 2004 and 2008. The lifetime medical cost of CP was calculated from the data and discount rate of 3%.
RESULTS: The prevalence of CP in South Korea was 2.6 per 1000 children. The attributable lifetime medical cost of CP in South Korea was calculated to be 26,383 US dollars, which is 1.8 times the basic lifetime medical cost of the general population (14,579 US dollars). Spastic CP showed the highest attributable medical cost, followed by dyskinetic and ataxic CP. Spastic diplegia showed 1.4 times of the attributable lifetime medical cost of spastic hemiplegia.
CONCLUSIONS: The prevalence of CP in South Korea is comparable to that in other countries. CP is a disease with wide range of clinical features, and the medical cost according to the physiological types and extent of involvement should be considered.
Authors:
Moon Seok Park; Se Jin Kim; Chin Youb Chung; Dae Gyu Kwon; In Ho Choi; Kyoung Min Lee
Related Documents :
12457426 - Balancing the cost and value of medications: the dilemma facing clinicians.
11558696 - Is technological change in medicine worth it?
9403166 - Catheter ablation of accessory pathways.
22353146 - Hypertonic saline, not mannitol, should be considered gold-standard medical therapy for...
1517986 - Challenges and opportunities facing the ohio college of podiatric medicine.
17458396 - A descriptive analysis of authorship within medical journals, 1995-2005.
Publication Detail:
Type:  Journal Article     Date:  2010-10-16
Journal Detail:
Title:  Health policy (Amsterdam, Netherlands)     Volume:  100     ISSN:  1872-6054     ISO Abbreviation:  Health Policy     Publication Date:  2011 May 
Date Detail:
Created Date:  2011-04-20     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8409431     Medline TA:  Health Policy     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  234-8     Citation Subset:  H    
Copyright Information:
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.
Affiliation:
Department of Orthopaedic Surgery, Seoul National University Bundang Hospital, 300 Gumi-Dong, Bundang-Gu, Sungnam, Kyungki 463-707, Republic of Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Inhibition of mammalian target of rapamycin: two goals with one shot?
Next Document:  Angiosarcoma of the lung: 2 cases report and literature reviewed.